drmb has some valid points which should not be overlooked. It is...

drmb has some valid points which should not be overlooked. It is clear that VCR have struck a snag in relation to getting reimbursement in certain countries and working with government regulators in trial protocols.

There are many hurdles to get over and the race is still a long way from finishing. I dont agree about VCR being left behind in relation to other LVAD's coming onto the market....they are clearly miles ahead and are in the process of upgrading the 3rd gen device to a 4th gen device. Most companies are working on 2nd and 3rd gen devices....so VCR is staying ahead of the pack.

You have to ask yourself why there are so many companies investing so many millions of dollars trying to get an LVAD to market. There is obviously a large market out there with huge profits to be made. Even if Stem Cells and other therapies come along over the next decade, VCR should become profitable in 3 years time.

Who knows what lies ahead....I for one think that VCR has a future and am investing accordingly. High risk equals high reward (so they say).